Dynamic prediction: A challenge for biostatisticians, but greatly needed by patients, physicians and the public
暂无分享,去创建一个
Martin Schumacher | Monika Engelhardt | Gabriele Ihorst | Stefanie Hieke | M. Schumacher | G. Ihorst | M. Engelhardt | S. Hieke
[1] Martin Schumacher,et al. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer , 2013, BMC Medical Research Methodology.
[2] Thomas A Gerds,et al. Comparing predictions among competing risks models with time‐dependent covariates , 2013, Statistics in medicine.
[3] Willi Sauerbrei,et al. Comparison of procedures to assess non‐linear and time‐varying effects in multivariable models for survival data , 2011, Biometrical journal. Biometrische Zeitschrift.
[4] Martin Schumacher,et al. Measures of prediction error for survival data with longitudinal covariates , 2011, Biometrical journal. Biometrische Zeitschrift.
[5] Irwin Nazareth,et al. Landmark Models for Optimizing the Use of Repeated Measurements of Risk Factors in Electronic Health Records to Predict Future Disease Risk , 2018, American journal of epidemiology.
[6] Nathan Mantel,et al. Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant Data , 1974 .
[7] N. Weiss,et al. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. , 2013, Journal of the National Cancer Institute.
[8] H. Goldschmidt,et al. Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response , 2017, Cancer medicine.
[9] J Benichou,et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. , 1999, Journal of the National Cancer Institute.
[10] W. Sauerbrei,et al. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Dimitris Rizopoulos,et al. Joint Models for Longitudinal and Time-to-Event Data: With Applications in R , 2012 .
[12] A. Whittemore,et al. Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk , 2015, Journal of the National Cancer Institute.
[13] M. Schumacher,et al. Landmark prediction of nosocomial infection risk to disentangle short- and long-stay patients. , 2017, The Journal of hospital infection.
[14] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.
[15] M. Schumacher,et al. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores , 2016, Haematologica.
[16] Martin Schumacher,et al. Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over Time , 2015, Clinical Cancer Research.
[17] J. Crowley,et al. International staging system for multiple myeloma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Stephen W Duffy,et al. A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.
[19] H. Einsele,et al. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients , 2017, Haematologica.
[20] Andre H Crepaldi,et al. Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma , 2017, The New England journal of medicine.
[21] Konstantin Strauch,et al. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance , 2012, Breast Cancer Research.
[22] P. Moreau. How I treat myeloma with new agents. , 2017, Blood.
[23] Eric J Feuer,et al. Age‐conditional probabilities of developing cancer , 2003, Statistics in medicine.
[24] H. Putter,et al. Dynamic Prediction in Clinical Survival Analysis , 2011 .
[25] R B Geskus,et al. Dynamic prediction of recurrent events data by landmarking with application to a follow-up study of patients after kidney transplant , 2018, Statistical methods in medical research.
[26] H. Putter,et al. Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial. , 2015 .
[27] Mitchell H. Gail,et al. Absolute Risk: Methods and Applications in Clinical Management and Public Health , 2018 .
[28] Hein Putter,et al. Dynamic prediction of cumulative incidence functions by direct binomial regression. , 2018, Biometrical journal. Biometrische Zeitschrift.
[29] Jack Cuzick,et al. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density , 2018, JAMA oncology.
[30] Stephan Harbarth,et al. Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. , 2012, Journal of clinical epidemiology.
[31] Hein Putter,et al. Estimation and Prediction in a Multi‐State Model for Breast Cancer , 2006, Biometrical journal. Biometrische Zeitschrift.
[32] Per Kragh Andersen,et al. Competing Risks and Time‐Dependent Covariates , 2009, Biometrical journal. Biometrische Zeitschrift.
[33] G. Lockwood,et al. Conditional relative survival: a different perspective to measuring cancer outcomes. , 2013, Cancer epidemiology.
[34] Greg Yothers,et al. Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] S. Chambers,et al. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects , 2011 .
[36] M. Gail,et al. Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Thomas A Gerds,et al. Efron‐Type Measures of Prediction Error for Survival Analysis , 2007, Biometrics.
[38] James R. Anderson,et al. Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] Geert Molenberghs,et al. Dynamic predictions with time‐dependent covariates in survival analysis using joint modeling and landmarking , 2013, Biometrical journal. Biometrische Zeitschrift.
[40] Katherine S Panageas,et al. Dynamic prognostication using conditional survival estimates , 2013, Cancer.
[41] J R Anderson,et al. Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Aeilko H. Zwinderman,et al. Dynamic prediction of mortality among patients in intensive care using the sequential organ failure assessment (SOFA) score: a joint competing risk survival and longitudinal modeling approach , 2018 .
[43] J. Harousseau,et al. How I treat first relapse of myeloma. , 2017, Blood.
[44] C. Hill,et al. Prediction of the long‐term survival in breast cancer patients according to the present oncological status , 2002, Statistics in medicine.
[45] Leonhard Held,et al. Dynamic clinical prediction models for discrete time‐to‐event data with competing risks—A case study on the OUTCOMEREA database , 2018, Biometrical journal. Biometrische Zeitschrift.
[46] Tianxi Cai,et al. The Performance of Risk Prediction Models , 2008, Biometrical journal. Biometrische Zeitschrift.
[47] E Graf,et al. Quantifying the Predictive Performance of Prognostic Models for Censored Survival Data with Time‐Dependent Covariates , 2008, Biometrics.